Platelet-Derived Growth Factor Receptor Association with Na+/H+ Exchanger Regulatory Factor Potentiates Receptor Activity

ABSTRACT Platelet-derived growth factor (PDGF) is a potent mitogen for many cell types. The PDGF receptor (PDGFR) is a receptor tyrosine kinase that mediates the mitogenic effects of PDGF by binding to and/or phosphorylating a variety of intracellular signaling proteins upon PDGF-induced receptor dimerization. We show here that the Na+/H+ exchanger regulatory factor (NHERF; also known as EBP50), a protein not previously known to interact with the PDGFR, binds to the PDGFR carboxyl terminus (PDGFR-CT) with high affinity via a PDZ (PSD-95/Dlg/Z0-1 homology) domain-mediated interaction and potentiates PDGFR autophosphorylation and extracellular signal-regulated kinase (ERK) activation in cells. A point-mutated version of the PDGFR, with the terminal leucine changed to alanine (L1106A), cannot bind NHERF in vitro and is markedly impaired relative to the wild-type receptor with regard to PDGF-induced autophosphorylation and activation of ERK in cells. NHERF potentiation of PDGFR signaling depends on the capacity of NHERF to oligomerize. NHERF oligomerizes in vitro when bound with PDGFR-CT, and a truncated version of the first NHERF PDZ domain that can bind PDGFR-CT but which does not oligomerize reduces PDGFR tyrosine kinase activity when transiently overexpressed in cells. PDGFR activity in cells can also be regulated in a NHERF-dependent fashion by stimulation of the β2-adrenergic receptor, a known cellular binding partner for NHERF. These findings reveal that NHERF can directly bind to the PDGFR and potentiate PDGFR activity, thus elucidating both a novel mechanism by which PDGFR activity can be regulated and a new cellular role for the PDZ domain-containing adapter protein NHERF.

[1]  R. Lefkowitz,et al.  The β2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor* , 2000, The Journal of Biological Chemistry.

[2]  B. Wilson,et al.  Pasteurella multocida Toxin Stimulates Mitogen-activated Protein Kinase via Gq/11-dependent Transactivation of the Epidermal Growth Factor Receptor* , 2000, The Journal of Biological Chemistry.

[3]  C. Theillet,et al.  17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification , 1999, Oncogene.

[4]  A. Bretscher,et al.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the β2-adrenergic receptor , 1999, Nature.

[5]  B. Katzenellenbogen,et al.  Estrogen Receptor Regulation of the Na+/H+ Exchanger Regulatory Factor. , 1999, Endocrinology.

[6]  Yusuke Nakamura,et al.  Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers , 1999, Genes, chromosomes & cancer.

[7]  James M. Anderson,et al.  PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. , 1999, The Journal of clinical investigation.

[8]  C. Hovens,et al.  The Junction-associated Protein AF-6 Interacts and Clusters with Specific Eph Receptor Tyrosine Kinases at Specialized Sites of Cell–Cell Contact in the Brain , 1999, The Journal of cell biology.

[9]  R. Huganir,et al.  PDZ Proteins Bind, Cluster, and Synaptically Colocalize with Eph Receptors and Their Ephrin Ligands , 1998, Neuron.

[10]  R. Abagyan,et al.  Novel Anchorage of GluR2/3 to the Postsynaptic Density by the AMPA Receptor–Binding Protein ABP , 1998, Neuron.

[11]  C. Heldin,et al.  Signal transduction via platelet-derived growth factor receptors. , 1998, Biochimica et biophysica acta.

[12]  T. Pawson,et al.  PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Montell,et al.  Coordination of an Array of Signaling Proteins through Homo- and Heteromeric Interactions Between PDZ Domains and Target Proteins , 1998, The Journal of cell biology.

[14]  T. Gudermann,et al.  Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Welsh,et al.  A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Shenolikar,et al.  Structure-function of recombinant Na/H exchanger regulatory factor (NHE-RF). , 1998, The Journal of clinical investigation.

[17]  P. Schatz,et al.  Peptide binding consensus of the NHE‐RF‐PDZ1 domain matches the C‐terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR) , 1998, FEBS letters.

[18]  L. Graves,et al.  Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G–protein coupled receptor–EGF receptor transactivation pathway , 1998, The EMBO journal.

[19]  S. Shenolikar,et al.  The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange , 1998, Nature.

[20]  S. Snyder,et al.  CAPON: A Protein Associated with Neuronal Nitric Oxide Synthase that Regulates Its Interactions with PSD95 , 1998, Neuron.

[21]  J. Gusella,et al.  NHE-RF, a Regulatory Cofactor for Na+-H+Exchange, Is a Common Interactor for Merlin and ERM (MERM) Proteins* , 1998, The Journal of Biological Chemistry.

[22]  A. Ullrich,et al.  Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.

[23]  Robert J. Lefkowitz,et al.  Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.

[24]  A. Bretscher,et al.  Identification of EBP50: A PDZ-containing Phosphoprotein that Associates with Members of the Ezrin-Radixin-Moesin Family , 1997, The Journal of cell biology.

[25]  E. Peralta,et al.  The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity , 1997, The EMBO journal.

[26]  K. Cooney,et al.  A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors , 1997, Oncogene.

[27]  M. Donowitz,et al.  cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Desclozeaux,et al.  The Human Testis Determining Factor SRY Binds a Nuclear Factor Containing PDZ Protein Interaction Domains* , 1997, The Journal of Biological Chemistry.

[29]  D. Bredt,et al.  Cloning and Characterization of Postsynaptic Density 93, a Nitric Oxide Synthase Interacting Protein , 1996, The Journal of Neuroscience.

[30]  C. Wernstedt,et al.  Mutation of a Src phosphorylation site in the PDGF beta‐receptor leads to increased PDGF‐stimulated chemotaxis but decreased mitogenesis. , 1996, The EMBO journal.

[31]  E. Petty,et al.  Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on l7q25 , 1996, Genes, chromosomes & cancer.

[32]  R. Liddington,et al.  Crystal structure of a PDZ domain , 1996, Nature.

[33]  John H. Lewis,et al.  Crystal Structures of a Complexed and Peptide-Free Membrane Protein–Binding Domain: Molecular Basis of Peptide Recognition by PDZ , 1996, Cell.

[34]  Stuart K. Kim,et al.  LET-23 Receptor Localization by the Cell Junction Protein LIN-7 during C. elegans Vulval Induction , 1996, Cell.

[35]  D. Bredt,et al.  Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.

[36]  K Anan,et al.  Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. , 1996, Surgery.

[37]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[38]  A. Kazlauskas,et al.  Identification of a Putative Syp Substrate, the PDGFβ Receptor (*) , 1995, The Journal of Biological Chemistry.

[39]  A. Gown,et al.  Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. , 1995, Cancer research.

[40]  C. Benjamin,et al.  Convergence of Angiotensin II and Platelet-derived Growth Factor Receptor Signaling Cascades in Vascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[41]  S. Shenolikar,et al.  Characterization of a protein cofactor that mediates protein kinase A regulation of the renal brush border membrane Na(+)-H+ exchanger. , 1995, The Journal of clinical investigation.

[42]  W. Fantl,et al.  Activation of Na+/H+ exchange by platelet-derived growth factor involves phosphatidylinositol 3'-kinase and phospholipase C gamma. , 1994, The Journal of biological chemistry.

[43]  C. Heldin,et al.  Ligand-induced ubiquitination of the platelet-derived growth factor beta-receptor plays a negative regulatory role in its mitogenic signaling. , 1993, The Journal of biological chemistry.

[44]  U. Hellman,et al.  Identification of two C‐terminal autophosphorylation sites in the PDGF beta‐receptor: involvement in the interaction with phospholipase C‐gamma. , 1992, The EMBO journal.

[45]  J. Schlessinger,et al.  Differential effects of carboxy-terminal sequence deletions on platelet-derived growth factor receptor signaling activities and interactions with cellular substrates , 1992, Molecular and cellular biology.

[46]  C. Heldin,et al.  Identification of a hydrophobic region in the carboxyl terminus of the platelet-derived growth factor beta-receptor which is important for ligand-mediated endocytosis. , 1991, The Journal of biological chemistry.

[47]  P. Phillips,et al.  Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. , 1989, The Journal of biological chemistry.

[48]  A. Ullrich,et al.  Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. , 1986, The Journal of biological chemistry.

[49]  P. Rothenberg,et al.  Platelet-derived growth factor stimulates Na+/H+ exchange and induces cytoplasmic alkalinization in NR6 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R. Lefkowitz,et al.  The b2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor* , 2000 .

[51]  B. Katzenellenbogen,et al.  Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. , 1999, Endocrinology.